Source: Annual Congress 2009 - Interesting case reports and case series



Rating:

Share or cite this content

Citations should be made in the following way:
K. Zycinska, K. Wardyn, T. Zielonka (Warsaw, Portugal; Warsaw, Poland). Early death prediction model in intestinal lung disease due to Wegener‘s granulomatosis. Eur Respir J 2009; 34: Suppl. 53, 3485

Member's Comments

No comment yet.

Related content which might interest you: Nasal carriage of Staphylococcus aureus and relapse rate in intestinal lung disease due to Wegener‘s granulomatosis Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis Source: Eur Respir J 2010; 36: 187-195 Year: 2010 A case of Wegener granulomatosis that mimics metastatic pulmonary tumor and progresses with eosinophilia Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 Bronchocentric granulomatosis and pulmonary tumourlet mimicking lung cancer Source: Annual Congress 2008 - Various thoracic tumours and interesting cases Year: 2008 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Prediction of chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003 Disease pathology in interstitial lung disease Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Alveolar hemorrhage in wegener's granulomatosis: importance of an early diagnosis and a target therapeutic approach Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease Source: Breathe, 16 (1) 190319; 10.1183/20734735.0319-2019 Year: 2020 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 Year: 2019 Early diagnosis of small airway disease Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020